Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Capecitabine|DRUG: Docetaxel
Sponsor: NSABP Foundation Inc
Collaborators: Genentech, Inc.|Hoffmann-La Roche|International Drug Development Institute